Cannabis Law Report

JUNE 5, 2021

After leaving their home in Northern Ireland, Charlotte Caldwell and 15-year-old Billy, who suffers from refractory epilepsy and autism, have crossed by ferry to Great Britain on an expedition scheduled to end at the Houses of Parliament at Westminster on June 14. The Caldwells have three primary goals in mind as they journey across the U.K.

Access

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. TSC is typically diagnosed in childhood. (5)

Pharmaceutical

Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. The Innovative Licensing and Access Pathway (ILAP) Innovation Passport has ben granted to MDMA as an adjunct to therapy for posttraumatic stress disorder (PTSD) in the United Kingdom (UK).

Therapy

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy

MMJ Recs

NOVEMBER 20, 2023

Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. Researchers have been conducting clinical studies to investigate the safety and efficacy of cannabinoid-based treatments. Image by Pfüderi from Pixabay.

Cannabinoids

MMJ Recs

NOVEMBER 17, 2023

Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies. MMJ is known for its efficacy in treating various medical issues, including chronic pain, epilepsy, multiple sclerosis, and more. It oversees licensing, quality control, and patient access.

Chronic Pain

United Patients Group

AUGUST 28, 2023

In this comprehensive guide, United Patients Group , the leading source for patient information on medical marijuana, will explore the current state of research and knowledge on CBD for pets, touching on the potential benefits, safety considerations, and best practices for incorporating CBD products into a pet’s wellness regimen.

Pets

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. References Staff, T.

Conditions

MMJ Recs

DECEMBER 28, 2023

However, more research is needed to establish standardized treatment protocols and ensure the long-term safety and efficacy of medical marijuana in managing PTSD. CBD has emerged as a potential anticonvulsant, with several studies suggesting its effectiveness in reducing seizure frequency in certain types of epilepsy.

Conditions

Veriheal

APRIL 11, 2022

I look forward to a time when they are not considered alternative therapies or home remedies but actually first-line therapies,” said the CEO of Zelira, Oludare Odumosu. “I look forward to a time when they are not considered alternative therapies or home remedies but actually first-line therapies,” said the CEO of Zelira, Oludare Odumosu. “We

Pharmaceutical

MMJ Recs

MAY 25, 2024

However, dysregulation of the endocannabinoid system has been implicated in the pathogenesis of neurological disorders such as epilepsy, multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease. Overall, by targeting the ECS, cannabis therapy offers a holistic approach to symptom relief for various medical conditions.

Patients

Veriheal

MAY 17, 2021

She ends the column by stating “ I urge our legislators to abandon this legislation for the sake of our citizen’s health and safety.”. The bill would also only allow patients that are qualified for their program to utilize products such as oral tablets, gels, creams, lozenges, and patches.

Legalization

Cannabis Law Report

AUGUST 21, 2019

The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result. This would answer questions about safety and efficacy, they said.

Clinical Trials

Veriheal

NOVEMBER 10, 2020

Despite the fact that there are still months before the start of this experiment, Nicolas Authier (chair of the French Agency for Safety of Medicines and Health Products, or ANSM) stated that France is now officially committed to giving citizens access to medical cannabis. .

Chronic Pain

Otherside Farms

NOVEMBER 10, 2019

In addition to the use of conventional therapies in treating autism, some homeopathic methods and products from nature will bring many enhancements to patients. People diagnosed with autism often suffer from neurological disorders such as epilepsy. Safety of Use. Symptoms that Cannabidiol Treat.

Therapy

PrestoDoctor

JULY 26, 2023

CBD, or cannabidiol, has been making headlines in the world of medicine and alternative therapies for some time now. Epilepsy is a common neurological disorder in pets, and traditional medications may come with unwanted side effects. However, it’s crucial to prioritize safety and consider the potential side effects.

Pets

Miss Marijuana

JUNE 7, 2019

Its positive effects are making waves in the medical community for patients with untreatable diseases and chronic pain, like Epilepsy , Parkinson’s and Multiple Sclerosis. 3. Testing process because safety y’all. Currently, research is finding CBD oil to be a complementary therapy for cancer symptoms, like pain and nausea.

Oil

Cannabis Law Report

FEBRUARY 1, 2022

Medical cannabis and psychedelics are being increasingly recognised by health professionals for their superior safety and efficacy compared to conventional pharmaceuticals. However, a sacred place is never empty and radically new therapies emerge quickly, which is what we see happening with psychedelic medicine.

Pharmaceutical

PrestoDoctor

APRIL 3, 2020

Delivering this alternative care with safety and compassion lead us to become the #1 patient-rated online medical marijuana recommendation platform today. Learn more about this exciting news! The Trusted Online Recommendation Platform. Easier access to alternative care is the driving mission at PrestoDoctor.

Marijuana

Puff Puff Post

DECEMBER 28, 2018

We go deep into what this might mean for the future of therapy for Autism Spectrum Disorders (ASD), and how we might see the use of CBD oil for autism. Success rates of up to 80% have been observed for CBD related autism therapy. Beyond alternative therapies, education and medication are the two most accepted ways of treating autism.

Treatment

Cannabis Law Report

DECEMBER 11, 2021

Dr Simon Erridge, Head of Research and Access at Sapphire Medical Clinics, commented: “As a multi-award-winning medical cannabis clinic, we are delighted to further improve access to this treatment option where other therapies haven’t worked. “By

Access

PrestoDoctor

SEPTEMBER 25, 2018

Delivering this alternative care with safety and compassion lead us to become the #1 patient-rated online medical marijuana recommendation platform today. Learn more about this exciting news! The Trusted Online Recommendation Platform. Easier access to alternative care is the driving mission at PrestoDoctor. Parkinson’s disease. Neuropathies.

Marijuana

MMJ Recs

JULY 5, 2024

Neurological Disorders Research suggests THC may benefit neurological conditions such as epilepsy, multiple sclerosis (MS), and Parkinson’s disease. Numerous clinical trials are underway to further investigate THC’s efficacy, safety, and potential interactions with other medications as well.

THC

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., Selling unapproved products with unsubstantiated therapeutic claims can put patients and consumers at risk.

CBD

MMJ Recs

JANUARY 24, 2024

The regulatory framework encompasses licensing, cultivation, and distribution, emphasizing safety and accountability. These dispensaries operate under strict state regulations, ensuring product safety and quality. Subsequently, in 2018, Michigan voters approved the recreational use of marijuana for adults, expanding legal access.

Programs

MMJ Recs

MARCH 6, 2024

Additionally, research suggests that cannabinoids found in marijuana may have neuroprotective properties, making them potentially beneficial in the treatment of neurological disorders like epilepsy and multiple sclerosis. Moreover, its use in palliative care has shown promising results in improving quality of life for terminally ill patients.

Marijuana

MMJ Recs

JUNE 19, 2024

The CUP also ensures that medical marijuana products meet stringent quality and safety standards, providing patients with access to reliable and effective treatments. As Texas continues to expand its medical marijuana program, more patients may find relief through cannabis-based therapies, improving their well-being and quality of life.

Conditions

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Refractory paediatric epilepsy. At the same time, the outlook on cannabis research data is largely positive. Conclusions.

Research and Development

PrestoDoctor

AUGUST 2, 2023

Conditions include chronic pain, epilepsy, multiple sclerosis, cancer, and post-traumatic stress disorder (PTSD). One of the key advantages of medical cannabis is its potential to offer a natural and alternative option for patients who have not found relief through traditional medications or therapies.

Conditions

Cannabis Law Report

JANUARY 6, 2020

While CBD cannot cure epilepsy, it can help with the quality of life that people with epilepsy are dealing. The Safety of CBD. These products are not intended to diagnose, treat, therapy or stop any disease. It can be used to improve social function, focus, language skills, and communication. By Alex Malkin.

Oil

MMJ Recs

MARCH 2, 2024

Additionally, adhering to dispensary policies on product handling and consumption promotes harmony and safety. A: Qualifying medical conditions in Ohio include cancer, PTSD, chronic pain, epilepsy, and more. Observing discretion in discussions regarding medical conditions and treatment enhances privacy and respect among patrons.

Dispensary

Cannabis Law Report

NOVEMBER 16, 2021

Food and Drug Administration clearance of its Investigational New Drug (IND) application for the Phase 2 trial of MYMD-1 as a therapy for delaying aging and prolonging healthy lifespan. The secondary measures will be the safety, tolerability, and pharmacokinetics in this population of patients. a driver of chronic inflammation.

Pharmaceutical

MMJ Recs

MAY 29, 2024

These dispensaries must adhere to strict regulations regarding product safety, labeling, and security. Consultation: Schedule consultations with prospective physicians to discuss your medical condition, treatment options, and their experience with medical marijuana therapy.

Marijuana

Cannabis Law Report

SEPTEMBER 4, 2019

One of them is conducted last year “Going Green: Use of Medical Cannabis in Medical Nutrition Therapy” where it is discussed about the research details on the benefits of cannabis and the risks involved and applications of cannabis in diagnosis. FDA’s opinion on CBD oil.

Oil

Cannabis Law Report

OCTOBER 26, 2021

an organization that provides support to pharmaceutical and biotech companies in North America, Europe, Japan, India and Africa on issues such as product safety, pharmacovigilance, medical devices, clinical trials and regulatory issues. Unlike other therapies, MYMD-1 has been shown to selectively block TNF-?

Pharmaceutical

MMJ Recs

OCTOBER 2, 2023

Common qualifying conditions include chronic pain, cancer, HIV/AIDS, multiple sclerosis, epilepsy, and glaucoma, among others. These dispensaries prioritize patient education and safety, providing a professional and comfortable experience for all visitors.

Dispensary

Canna Law Blog

DECEMBER 16, 2021

Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. Psilocybin therapy is a breakthrough avenue for providing people with treatment for these ailments.

Legislation